How many institutions held PPCB - Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share in Q3 2025?

3 institutional investors reported PPCB - Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share for Q3 2025. Use the holders table for investor-level position and value details.

Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB)

Q: What does CUSIP 74346N701 represent in this 13F holders report?

CUSIP 74346N701 is the security identifier for PPCB - Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 74346N701

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 12,703,253
Total 13F shares: 112,107
Share change: +112,107
Total reported value: $190,731
Price per share: $1.70
Number of holders: 3
Value change: +$190,731
Number of buys: 3

Quarterly Holders Quick Answers

What is CUSIP 74346N701?
CUSIP 74346N701 identifies PPCB - Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2025

Recent filing periods for CUSIP 74346N701:

Q4 2025 Q3 2025

Institutional Holders of Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB) as of Q3 2025

As of 30 Sep 2025, Propanc Biopharma, Inc. - Common Stock, par value $0.001 per share (PPCB) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 112,107 shares. The largest 3 holders included Marex Group plc, Virtu Financial LLC, and MORGAN STANLEY. This page lists 3 institutional shareholders reporting positions in this security for the Q3 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.